Promecon

Promecon - General Information

Promecon is an antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors.

Pharmacology of Promecon

Promecon is an antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties.

Additional information about Promecon

Promecon Indication: Used to prevent and treat nausea and vomiting associated with anesthesia and surgery, administered intramuscularly or intravenously.
Mechanism Of Action: The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Benzquinamide
Synonyms: Not Available
Drug Category: Antiemetics; Antipsychotics
Drug Type: Small Molecule; Approved

Other Brand Names containing Benzquinamide: BZQ; Benzchinamide; Emete-con; Emeticon; Promecon; Quantril;
Absorption: Incomplete, with 33–39% bioavailability via the capsule and suppository routes, relative to the intramuscular route.
Toxicity (Overdose): Not Available
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: 1-1.6 hours (for all formulations)
Dosage Forms of Promecon: Not Available
Chemical IUPAC Name: [3-(diethylcarbamoyl)-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl] acetate
Chemical Formula: C22H32N2O5
Benzquinamide on Wikipedia: Not Available
Organisms Affected: Humans and other mammals